Cytokine-pathway blockers worsen mycosis fungoides masquerading as psoriasis

• Gabriela Blanchard, MD, PhD,
• Bettina Bisig, MD, PhD,
• Laurence de Leval, MD, PhD,
• Daniel Hohl, MD,
• Emmanuella Guenova, MD, PhD

Affiliations

Gabriela Blanchard, MD, PhD

Department of Dermatology and Venereology, Lausanne University Hospital (CHUV), Lausanne, Switzerland; Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland; Division of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland

Bettina Bisig, MD, PhD

Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland

Laurence de Leval, MD, PhD

Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland

Daniel Hohl, MD

Department of Dermatology and Venereology, Lausanne University Hospital (CHUV), Lausanne, Switzerland; Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland

Emmanuella Guenova, MD, PhD

Department of Dermatology and Venereology, Lausanne University Hospital (CHUV), Lausanne, Switzerland; Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland; Correspondence to: Emmanuella Guenova, MD, PhD, Prof., Department of Dermatology, Lausanne University Hospital (CHUV); Faculty of Biology and Medicine, University of Lausanne, Avenue de Beaumont 29, 1011 Lausanne, Switzerland.